CLBT
CLBT
NASDAQ · Technology

Cellebrite Di Ltd

$14.21
-0.63 (-4.25%)
As of Mar 24, 9:58 PM ET ·
Financial Highlights (FY 2026)
Revenue
493.75M
Net Income
81.30M
Gross Margin
84.2%
Profit Margin
16.5%
Rev Growth
+20.7%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 84.2% 84.2% 34.9% 34.9%
Operating Margin 14.0% 12.6% 23.1% 21.8%
Profit Margin 16.5% 15.7% 16.9% 18.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 493.75M 409.17M 688.80M 631.53M
Gross Profit 415.74M 344.52M 240.06M 220.10M
Operating Income 69.03M 51.48M 158.95M 137.39M
Net Income 81.30M 60.63M 116.55M 115.17M
Gross Margin 84.2% 84.2% 34.9% 34.9%
Operating Margin 14.0% 12.6% 23.1% 21.8%
Profit Margin 16.5% 15.7% 16.9% 18.2%
Rev Growth +20.7% +20.7% -6.8% +15.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 373.27M 415.63M
Total Equity 2.18B 1.99B
D/E Ratio 0.17 0.21
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 82.05M 64.60M 223.67M 228.90M
Free Cash Flow 62.94M 97.33M